News for Filament Health Corp. (FH.NE)

Published at

Feb 27, 2025 6:00 PM

by gurufocus.com

mixed

mixed

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestin

FLHLF FH.NE JAGX

Read more →
Published at

Feb 18, 2025 6:00 PM

by gurufocus.com

mixed

mixed

Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300

Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million1.3 to 4 million cholera c

FLHLF FH.NE JAGX

Read more →
Published at

Jan 11, 2025 2:00 AM

by gurufocus.com

mixed

mixed

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective January 8, 202

FLHLF FH.NE JAGX

Read more →
Published at

Jan 7, 2025 6:00 PM

by gurufocus.com

mixed

mixed

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate fo

FLHLF FH.NE JAGX

Read more →
Published at

Dec 17, 2024 6:00 PM

by gurufocus.com

mixed

mixed

FDA Approves Orphan-Drug Designation for Jaguar Health's Crofelemer for Treatment of Diarrhea in Cholera

World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to 4 million cholera cases an

FLHLF FH.NE JAGX

Read more →
Published at

Dec 13, 2024 6:00 PM

by gurufocus.com

mixed

mixed

Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer

Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - for the rare disease i

FLHLF FH.NE JAGX

Read more →
Published at

Dec 12, 2024 6:00 PM

by gurufocus.com

mixed

mixed

Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)

Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTDThe m

FLHLF FH.NE JAGX

Read more →
Published at

Dec 6, 2024 6:00 PM

by gurufocus.com

mixed

mixed

U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health's Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) Begins

The study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-I

FLHLF FH.NE JAGX

Read more →
Published at

Nov 25, 2024 6:00 PM

by gurufocus.com

mixed

mixed

Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference

SAN FRANCISCO, CA / ACCESSWIRE / November 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO

FLHLF FH.NE JAGX

Read more →
Published at

Nov 22, 2024 6:00 PM

by gurufocus.com

mixed

mixed

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet the

FLHLF FH.NE JAGX

Read more →
Published at

Nov 19, 2024 6:00 PM

by gurufocus.com

mixed

mixed

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe”

Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription drug, in Europ

FLHLF FH.NE JAGX

Read more →
Published at

Oct 11, 2024 10:28 PM

by investing.com

positive

positive

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

JAGX FLHLF FH.NE

Read more →
Published at

Jul 26, 2024 3:33 PM

by financialpost.com

positive

positive

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“

PSYG.CN FLHLF FH.NE

Read more →
Published at

Apr 5, 2024 4:30 PM

by investorideas.com

mixed

mixed

Biotech Sector a Healthy Choice for Investors? (Nasdaq: ELTX) (Nasdaq: VRDN) (Nasdaq: KZIA) (Nasdaq: RGLS)

April 5, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watch i...

VRDN RGLS OTRKP OTRK FLHLF FH.NE EVTCY EVTA.DE EVT.DE EVOTF DCYHY DCYHF BETRF BETR.CN AUVIP AUVI AMLYY AMLTF KZIA

Read more →
Published at

Dec 20, 2023 5:30 AM

by globenewswire.com

positive

positive

Jupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Pu

Hobe Sound, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced the mutually agreed...

JAQCU FLHLF FH.NE

Read more →
Published at

Jul 20, 2022 9:50 PM

by stockhead.com.au

mixed

mixed

Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

In a ground-breaking development, the US FDA has just approved a clinical trial studying the effects of naturally derived psychedelic drugs.

ZNO.AX TD1.AX RNO.AX PYC.AX NXSCF NXS.AX MDC.AX IPDQF IPD.AX GSS.AX FH.NE FDMDF CAN.AX CAJ.AX BXN.AX BITRF BIT.AX ADR.AX 4DX.AX 1ST.AX VLS.AX RGS.AX RAP.AX RAC.AX PSQ.AX PCK.AX PBP.AX PAL.AX OSL.AX ONE.AX OCC.AX NC6.AX MXC.AX MX1.AX MDR.AX LGP.AX KZA.AX IVX.AX IMRNW IMRN IMC.AX EMD.AX BWXXF BWX.AX ATX.AX AMT.AX AMDHF 1AD.AX ZLD.AX VTG.AX UBI.AX SOMNF SOM.AX SCU.AX RSH.AX RHY.AX RHT.AX PXSLY PXS.AX PNV.AX PGC.AX PAB.AX OVN.AX OSX.AX OPT.AX OPT OIL.AX NYR.AX NOXOF NOX.AX MVF.AX MEM.AX MEB.AX MDBIF LBT.AX KMLXF IUGNF IMU.AX IMM.AX IHL.AX IDT.AX ICR.AX HCT.AX GTG.AX GLH.AX FFC.AX EYE.AX DXB.AX DVL.AX CYP.AX CPH.AX CMP.AX CKDXF CGS.AX CALZF BPH.AX BNOEF BNO.AX AT1.AX ARX.AX ARUXF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jun 15, 2022 6:32 PM

by benzinga.com

mixed

mixed

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

OPTHF NVMDF NUMI.V MSSTF LKYSF JAGX GTSIF FLHLF FH.NE ENTBF ENBI.CN CYBN.NE CYBN CLXPF SILO.CN SILFF TRYPF

Read more →
Published at

May 13, 2022 4:10 PM

by investorideas.com

mixed

mixed

New Stocks and Trading Ideas: (NYSE: LEV; TSX: LEV) (Nasdaq: DCFC) (NasdaqCM: AGFY) (TSXV: PSYB) (NasdaqCM: FTHM) (NYSE: VSTO)

Vancouver, Kelowna, Delta, BC - May 13, 2022 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its w...

XPOF VSTO VRNOF VRNO.CN PSYBF PSYB.V NVVEW NVVE MGA MG.TO LRN LEV.TO LEV GLASF GLAS-A.NE GAN FRGAP FLHLF FH.NE AGFY REAXF REAXD REAX.V FTHM ENVB

Read more →
Published at

Apr 25, 2022 11:55 PM

by benzinga.com

mixed

mixed

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education.

PSYCF PSYC.CN NMDBF FLHLF FH.NE ENVB DCNPF CMPS ATAI CYBN.NE CYBN CLXPF

Read more →